According to REGENXBIO's latest financial reports the company has ยฃ0.20 Billion in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2024-12-31 | $ยฃ0.20 B | -15.44% |
2023-12-31 | $ยฃ0.24 B | -42.65% |
2022-12-31 | $ยฃ0.42 B | -24.64% |
2021-12-31 | $ยฃ0.56 B | 104.31% |
2020-12-31 | $ยฃ0.27 B | -19.28% |
2019-12-31 | $ยฃ0.34 B | -14.36% |
2018-12-31 | $ยฃ0.40 B | 196.01% |
2017-12-31 | $ยฃ0.13 B | 3.32% |
2016-12-31 | $ยฃ0.13 B | -10.41% |
2015-12-31 | $ยฃ0.14 B | -4097.51% |
2014-12-31 | $-ยฃ3.66 Million | 181.7% |
2013-12-31 | $-ยฃ1.3 Million |
Company | Net assets | differencediff. | Country |
---|---|---|---|
![]() ORIC Pharmaceuticals
ORIC | ยฃ0.16 B | -19.86% | ๐บ๐ธ USA |